Trial Information
The Significance of Sentinel Node Analysis in Colon Cancer
Inclusion Criteria:
- All patients must consent to participate in study
- Patients will be tracked for five years
- A blood test (CEA) will be collected every six months
- A CT scan will be performed annually
- A colonoscopy will be performed at 1 and 5 years post-surgery
Type of Study:
Interventional
Study Design:
Allocation: Non-Randomized, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Principal Investigator
Mark Whiteford, MD
Investigator Role:
Principal Investigator
Investigator Affiliation:
Legayc Health System
Authority:
United States: Institutional Review Board
Study ID:
750040399
NCT ID:
NCT00419978
Start Date:
June 2004
Completion Date:
May 2008
Related Keywords:
- Colon Cancer
- Colonic Neoplasms
Name | Location |
Legacy Good Samaritan Hospital and Medical Center |
Portland, Oregon 97210 |